Myocardial phenotypes and dysfunction in HFpEF and HFrEF assessed by echocardiography and cardiac magnetic resonance

Bostjan Berlot1,2, Chiara Bucciarelli-Ducci3, Alberto Palazzuoli4

  • 1Department of Cardiology, University Medical Centre Ljubljana, Zaloska cesta 7, 1000, Ljubljana, Slovenia.

Heart Failure Reviews
|November 15, 2019
PubMed

Insights

Cardiac imaging, including echocardiography and cardiac magnetic resonance, is crucial for diagnosing heart failure (HF) and guiding personalized treatment. This review explores their roles in assessing cardiac function and tissue in various HF phenotypes.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Heart failure (HF) is a growing global health concern, affecting both reduced and preserved ejection fraction.
  • Accurate diagnosis of systolic and diastolic dysfunction is essential for effective patient management and tailored therapies.

Purpose of the Study:

  • To review the roles of echocardiography and cardiac magnetic resonance in characterizing cardiac anatomy, function, and tissue in common heart failure phenotypes.
  • To highlight the benefits of an integrated imaging approach for heart failure with preserved ejection fraction (HFpEF).

Main Methods:

  • Review of current literature on echocardiography and cardiac magnetic resonance in heart failure diagnosis.
  • Comparative analysis of the strengths and limitations of each imaging modality.

Main Results:

  • Echocardiography and cardiac magnetic resonance are key imaging tools for evaluating heart failure.
  • Each modality offers unique insights into cardiac structure, systolic/diastolic function, and myocardial tissue characteristics.
  • An integrated approach may enhance diagnostic accuracy, particularly for HFpEF.

Conclusions:

  • Cardiac imaging is indispensable for understanding the pathophysiology of diverse heart failure types.
  • Optimizing the use of echocardiography and cardiac magnetic resonance, potentially in combination, can improve patient care and treatment strategies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
329
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
633
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
633
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
405
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
445